Metraipolis › archive › dc_ffde6ee5ba3d
Advances in the clinical application of bispecific antibodies in cancer therapy — Europe PMC PMID:41476945
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41476945
- DOI
- 10.1016/j.isci.2025.114203
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T06:55:42.990Z
- SHA-256 of the archived text
952bc993f424d3186c3cef589fc0948dd43d08dd86f14db950b9575e5a4d83ed- Stable URL of this page
https://metraipolis.com/documento/dc_ffde6ee5ba3d
How to cite
Advances in the clinical application of bispecific antibodies in cancer therapy — Europe PMC PMID:41476945 — Europe PMC (en), https://europepmc.org/article/MED/41476945 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ffde6ee5ba3d (Metraipolis archive dc_ffde6ee5ba3d, sha256 952bc993f424d3186c3cef589fc0948dd43d08dd86f14db950b9575e5a4d83ed)
BibTeX
@misc{dcffde6ee5ba3d,
title = {Advances in the clinical application of bispecific antibodies in cancer therapy — Europe PMC PMID:41476945},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41476945},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ffde6ee5ba3d; sha256 952bc993f424d3186c3cef589fc0948dd43d08dd86f14db950b9575e5a4d83ed},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41476945. Agents can read the archived copy with the MCP tool read_document.